Detalhe da pesquisa
1.
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
Proc Natl Acad Sci U S A
; 108(40): 16723-8, 2011 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21933959
2.
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
Proc Natl Acad Sci U S A
; 105(51): 20410-5, 2008 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19074257
3.
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Cancer Immun
; 9: 5, 2009 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19496531
4.
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.
Cytotherapy
; 11(7): 912-22, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19903103
5.
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.
Mol Ther
; 16(12): 2022-9, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18797450
6.
Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection.
Clin Cancer Res
; 16(15): 4057-65, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20647477
7.
A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen.
Clin Genitourin Cancer
; 10(2): 126-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22284755
8.
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.
Mol Ther
; 15(11): 2044-50, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17726460